Recursion Pharmaceuticals, Inc. (RXRX)
Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary 
XMEX $
2. 94
-0.08
-2.4834%
$
1.59B Market Cap
- P/E Ratio
- Div Yield
19.28M Volume
-1.72 Eps
$ 3.02
Previous Close 
Want to track RXRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
RXRX Earnings Reports FAQ
What is the earnings per share (EPS) for RXRX?
The current EPS is -1.72.
What is the company's earnings growth rate?
Recursion Pharmaceuticals, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Recursion Pharmaceuticals, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Recursion Pharmaceuticals, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for RXRX at this time, as Recursion Pharmaceuticals, Inc has no recent EPS data to calculate it.
